A2a Pharmaceuticals has a total of 12 patents globally, out of which 4 have been granted. Of these 12 patents, more than 83% patents are active. The United States of America is where A2a Pharmaceuticals has filed the maximum number of patents, followed by Europe (EPO) and Japan. Parallelly, United States of America seems to be the main focused R&D centre and also is the origin country of A2a Pharmaceuticals.
A2a Pharmaceuticals was founded in 2016. A2A Pharmaceuticals is a biotechnology business dedicated to advancing novel therapeutic agents and creative scientific research.
Do read about some of the most popular patents of A2a Pharmaceuticals which have been covered by us in this article and also you can find A2a Pharmaceuticals patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over A2a Pharmaceuticals patent portfolio.
How many patents does A2a Pharmaceuticals have?
A2a Pharmaceuticals has a total of 12 patents globally. These patents belong to 6 unique patent families. Out of 12 patents, 10 patents are active.
How Many Patents did A2a Pharmaceuticals File Every Year?
Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.
Year of Patents Filing or Grant | A2a Pharmaceuticals Applications Filed | A2a Pharmaceuticals Patents Granted |
2023 | 1 | 4 |
2022 | 3 | – |
2020 | 4 | – |
2019 | 4 | – |
How many A2a Pharmaceuticals patents are Alive/Dead?
Worldwide Patents
How Many Patents did A2a Pharmaceuticals File in Different Countries?
Countries in which A2a Pharmaceuticals Filed Patents
Country | Patent |
United States Of America | 3 |
Europe | 2 |
Japan | 2 |
Taiwan | 1 |
Canada | 1 |
Where are Research Centers of A2a Pharmaceuticals Patents Located?
What Percentage of A2a Pharmaceuticals US Patent Applications Were Granted?
A2a Pharmaceuticals (Excluding its subsidiaries) has filed 2 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 0 have been granted leading to a grant rate of 0%.
Below are the key stats of A2a Pharmaceuticals patent prosecution at the USPTO.
Which Law Firms Filed Most US Patents for A2a Pharmaceuticals?
Law Firm | Total Applications | Success Rate |
Foley Hoag Llp | 1 | 0% |
Oppenhuizen Law Plc | 1 | 0% |
List of A2a Pharmaceuticals patents
A2a Pharmaceuticals Patents | Title |
US11737796B2 | Proximal Femoral De-Rotation Nail |
US11622966B2 | Highly Potent Tacc3 Inhibitor As A Novel Anticancer Drug Candidate |
US20230027854A1 | Isoxazole Derivatives Targeting Tacc3 As Anticancer Agents |
EP3801529B1 | Highly Potent Tacc3 Inhibitor As A Novel Anticancer Drug Candidate |
EP4058447A1 | Isoxazole Derivatives Targeting Tacc3 As Anticancer Agents |
WO2023183520A1 | Compositions And Methods For Treating Cancer |
CA3216541A1 | Compositions And Methods For Treating Cancer |
JP7301958B2 | A Highly Potent Tacc3 Inhibitor As A Novel Anticancer Drug Candidate |
JP2023502602A | Isoxazole Derivatives Targeting Tacc3 As Anticancer Agents |
TW202304895A | Compositions And Methods For Treating Cancer |
WO2022221194A1 | Compositions And Methods For Treating Cancer |
WO2021097352A1 | Isoxazole Derivatives Targeting Tacc3 As Anticancer Agents |
What are A2a Pharmaceuticals key innovation segments?
What Technologies are Covered by A2a Pharmaceuticals?
The chart below distributes patents filed by A2a Pharmaceuticals